PHP
NSPR icon

Parkman Healthcare Partners’s InspireMD NSPR Stock Holding History

Parkman Healthcare Partners’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.94M Hold
2,416,518
– – 0.41% 67
2025
Q4 		$4.3M Sell
2,416,518
-24,115
-1% -$50.3K 0.41% 66
2025
Q3 		$5.88M Buy
2,440,633
+1,205,328
+98% +$2.92M 0.61% 58
2025
Q2 		$2.8M Buy
1,235,305
+63,889
+5% +$159K 0.32% 73
2025
Q1 		$3.15M Buy
1,171,416
+316,700
+37% +$896K 0.37% 64
2024
Q4 		$2.25M Buy
854,716
+750,635
+721% +$2.02M 0.3% 67
2024
Q3 		$279K Buy
+104,081
New +$284K 0.04% 93

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Parkman Healthcare Partners's NSPR Position: Q1 2026 in Review

Parkman Healthcare Partners held its InspireMD (NSPR) position steady in Q1 2026 at 2,416,518 shares worth $3.94M. The position accounts for 0.41% of the portfolio, ranked #67.

Parkman Healthcare Partners first reported a position in NSPR in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.88M in Q3 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Parkman Healthcare Partners held 2,416,518 shares of InspireMD worth $3.94M as of Q1 2026.
  • Parkman Healthcare Partners left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up 0.41% of Parkman Healthcare Partners's portfolio in Q1 2026, its #67 holding.
  • Parkman Healthcare Partners first reported a position in InspireMD in Q3 2024 and has held it in 7 quarters since.
  • Parkman Healthcare Partners's InspireMD position peaked at $5.88M in Q3 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.